top of page
Amyloidosis Management in 2025: Current and Future Therapies
Thu, Dec 11
|Live Webinar
Join the Canadian Cardiovascular Society (CCS) for Amyloid Education Series 2.0, Part 2: Amyloidosis Management in 2025 – Current and Future Therapies: CCS Position Statement & Beyond.
Registration is closed
See other events
Time & Location
Dec 11, 2025, 6:00 p.m. – 7:00 p.m.
Live Webinar
About the event
Learning Objectives:
By the end of this webinar, participants will be able to:
Describe the mechanisms in cardiac amyloidosis contributing to heart failure.
Apply evidence-based management strategies to optimize patient outcomes.
Evaluate current pharmacologic therapies for amyloidosis, including the roles of stabilizers and silencers.
Discuss emerging clinical evidence and novel therapies to assess their impact on the evolving landscape of amyloidosis management.
bottom of page